Franz X. Schaub
Publications by Year
Research Areas
Pancreatic function and diabetes, Lung Cancer Treatments and Mutations, Advanced Breast Cancer Therapies, Endoplasmic Reticulum Stress and Disease, Cancer Genomics and Diagnostics
Most-Cited Works
- → Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas(2018)438 cited
- → Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms(2010)173 cited
- → Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis(2015)118 cited
- → JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis(2007)118 cited
- → Tristetraprolin Impairs Myc-Induced Lymphoma and Abolishes the Malignant State(2012)118 cited
- → Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma(2014)94 cited
- → Hrr25/CK1δ-directed release of Ltv1 from pre-40S ribosomes is necessary for ribosome assembly and cell growth(2015)82 cited
- → Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F(2008)70 cited
- → TFEB Links MYC Signaling to Epigenetic Control of Myeloid Differentiation and Acute Myeloid Leukemia(2020)45 cited
- → BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer(2020)38 cited